GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » Equity-to-Asset

Sonoscape Medical (SZSE:300633) Equity-to-Asset : 0.81 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sonoscape Medical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥3,256 Mil. Sonoscape Medical's Total Assets for the quarter that ended in Mar. 2024 was ¥4,044 Mil. Therefore, Sonoscape Medical's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.81.

The historical rank and industry rank for Sonoscape Medical's Equity-to-Asset or its related term are showing as below:

SZSE:300633' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52   Med: 0.74   Max: 0.83
Current: 0.81

During the past 12 years, the highest Equity to Asset Ratio of Sonoscape Medical was 0.83. The lowest was 0.52. And the median was 0.74.

SZSE:300633's Equity-to-Asset is ranked better than
77.24% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs SZSE:300633: 0.81

Sonoscape Medical Equity-to-Asset Historical Data

The historical data trend for Sonoscape Medical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical Equity-to-Asset Chart

Sonoscape Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.59 0.78 0.77 0.83

Sonoscape Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 0.81 0.82 0.83 0.81

Competitive Comparison of Sonoscape Medical's Equity-to-Asset

For the Medical Devices subindustry, Sonoscape Medical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonoscape Medical's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonoscape Medical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sonoscape Medical's Equity-to-Asset falls into.



Sonoscape Medical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sonoscape Medical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=3145.954/3771.417
=0.83

Sonoscape Medical's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=3256.348/4043.654
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sonoscape Medical  (SZSE:300633) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sonoscape Medical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoscape Medical (SZSE:300633) Business Description

Traded in Other Exchanges
N/A
Address
Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.

Sonoscape Medical (SZSE:300633) Headlines

No Headlines